South America Malaria Treatment Market to 2028 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. South America Malaria Treatment Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. South America Malaria Treatment Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Increasing Prevalence of Malaria
5.1.2 Rising Initiatives to Raise Awareness about Malaria

5.2 Market Opportunities

5.2.1 Growing Strategic Initiatives by Market Players

5.3 Future Trends

5.3.1 Extending Pipeline of New Drugs and Vaccines

5.4 Impact of Drivers and Restraints

6. South America Malaria Treatment Market Regional Analysis

6.1 South America Malaria Treatment Market Overview

6.2 South America Malaria Treatment Market Revenue 2020-2028 (US$ Million)

6.3 South America Malaria Treatment Market Forecast Analysis

7. South America Malaria Treatment Market Analysis – by Treatment

7.1 Prescription Medications

7.1.1 Overview
7.1.2 Prescription Medications: South America Malaria Treatment Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Vaccines

7.2.1 Overview
7.2.2 Vaccines: South America Malaria Treatment Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Diagnostic Tests

7.3.1 Overview
7.3.2 Diagnostic Tests: South America Malaria Treatment Market – Revenue and Forecast to 2031 (US$ Million)

8. South America Malaria Treatment Market Analysis – by Drug Type

8.1 Branded and Generic

8.1.1 Overview
8.1.2 Branded and Generic: South America Malaria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9. South America Malaria Treatment Market Analysis – by Route of Administration

9.1 Oral and Parenteral & Intravenous

9.1.1 Overview
9.1.2 Branded and Generic: South America Malaria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10. South America Malaria Treatment Market – South and Central America Analysis

10.1 South and Central America

10.1.1 South America Malaria Treatment Market Breakdown, by Key Country, 2023 and 2028 (%)
10.1.1.1 South America Malaria Treatment Market – Revenue and Forecast Analysis – by Country
10.1.1.1 Brazil: South America Malaria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 Brazil: South America Malaria Treatment Market Breakdown, by Treatment
10.1.1.1.2 Brazil: South America Malaria Treatment Market Breakdown, by Drug Type
10.1.1.1.3 Brazil: South America Malaria Treatment Market Breakdown, by Route of Administration

10.1.1.2 Argentina: South America Malaria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 Argentina: South America Malaria Treatment Market Breakdown, by Treatment
10.1.1.2.2 Argentina: South America Malaria Treatment Market Breakdown, by Drug Type
10.1.1.2.3 Argentina: South America Malaria Treatment Market Breakdown, by Route of Administration

10.1.1.3 Rest of South and Central America : South America Malaria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 Rest of South and Central America : South America Malaria Treatment Market Breakdown, by Treatment
10.1.1.3.2 Rest of South and Central America : South America Malaria Treatment Market Breakdown, by Drug Type
10.1.1.3.3 Rest of South and Central America : South America Malaria Treatment Market Breakdown, by Route of Administration

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. South America Malaria Treatment Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 AdvaCare Pharma USA LLC

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Cipla Ltd

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 GSK Plc

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Lupin Ltd

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Novartis AG

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Sanofi SA

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Sun Pharmaceutical Industries Ltd

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Viatris Inc

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Zydus Healthcare Ltd

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights